Also trades as: 0HTG.L (LSE) · $vol 0M
CAH NYSE
Cardinal Health, Inc.
1W: +3.9%
1M: -7.0%
3M: -3.9%
YTD: +10.9%
1Y: +44.5%
3Y: +169.6%
5Y: +393.6%
$228.30
-1.79 (-0.78%)
Weekly Expected Move ±3.1%
$214
$221
$228
$235
$242
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships11
As Filer
counterparties named
1
As Counterparty
mentioned by others
3
Rel. Types
2022-05-03
Earliest Filing
2024-12-09
Latest Filing
target: 5
partner: 3
investor: 3
Counterparties (Filed by CAH)
11 relationshipsCompanies named in CAH's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| The GI Alliance Holdings, LLC | — | target | Target of the proposed Cure Merger Agreement acquisition | 2024-12-09 | View |
| Advanced Diabetes Supply Group | — | target | Target of the proposed Merger Agreement acquisition | 2024-12-09 | View |
| The GI Alliance Holdings, LLC | — | target | Target of proposed acquisition (GIA Acquisition) | 2024-11-22 | View |
| Advanced Diabetes Supply Group | — | target | Target of proposed acquisition | 2024-11-22 | View |
| The GI Alliance Holdings, LLC | — | target | Target of the $2.8 billion acquisition by Cardinal Health, Inc. | 2024-11-12 | View |
| Cure Acquisitionco, LLC | — | partner | Wholly owned subsidiary of Cardinal Health, Inc. used to acquire The GI Alliance Holdings, LLC. | 2024-11-12 | View |
| Elliott Associates, L.P. | — | investor | Investor in the Company's Board of Directors | 2023-05-04 | View |
| Elliott International, L.P. | — | investor | Investor in the Company's Board of Directors | 2023-05-04 | View |
| Elliott International Capital Advisors Inc. | — | investor | Investor in the Company's Board of Directors | 2023-05-04 | View |
| Elliott Associates, L.P. | — | partner | Entered into a Cooperation Agreement with Cardinal Health, Inc. | 2022-09-06 | View |
| Elliott International, L.P. | — | partner | Entered into a Cooperation Agreement with Cardinal Health, Inc. | 2022-09-06 | View |
Mentioned As Counterparty
1 mentionsOther companies that named CAH in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-01 | Regulation FD; Exhibits | View | |
| 2026-08-11 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-08-11 | Material Agreement; Termination of Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-08-05 | Officer/Director Change | View | |
| 2026-04-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-23 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-03-05 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-02-05 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-06 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-10-30 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-10 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-10-03 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-27 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-08-14 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-06-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-05-01 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-03-10 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-01-30 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR